blog.parabasegenomics.com
Product Variation 2
http://blog.parabasegenomics.com/products/product-1/variation-2
Enter your page name. Matching Newborns to Rare Therapeutics. Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics’ Targeted Next Generation Sequencing Testing Platform. When the Target Market is Right, Prognosis for Diagnostic Start-Ups is Bright. Limitations of Hearing Loss Testing in Newborns. About The Business Theme. Monthly Newsletter Sign Up. Sign up to revieve our monthly newsletter filled with awesome news about our super products and solutions. Business Theme, Inc.
blog.parabasegenomics.com
When the Target Market is Right, Prognosis for Diagnostic Start-Ups is Bright
http://blog.parabasegenomics.com/blog/prognosis-for-diagnostic-start-ups-is-bright
When the Target Market is Right, Prognosis for Diagnostic Start-Ups is Bright. Mar 27, 2014 10:49:00 PM. Gabor Bethlendy, Rina Wolf, and Arindam Bhattacharjee, PhD. Gabor Bethlendy and Arindam Bhattacharjee, Parabase Genomics, Boston, MA, USA. Rina Wolf, XiFin,. San Diego, CA. That gravy train is going to take a severe slow down in the coming years as it forces hospitals into Accountable Care Organizations. While it is true there have been some reports from SVB. Specifically, when it comes to recessive d...
blog.parabasegenomics.com
Management Team
http://blog.parabasegenomics.com/about-us/management-team
Enter your page name. Matching Newborns to Rare Therapeutics. Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics’ Targeted Next Generation Sequencing Testing Platform. When the Target Market is Right, Prognosis for Diagnostic Start-Ups is Bright. Limitations of Hearing Loss Testing in Newborns. About The Business Theme. Monthly Newsletter Sign Up. Sign up to revieve our monthly newsletter filled with awesome news about our super products and solutions. Business Theme, Inc.
blog.parabasegenomics.com
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics’ Targeted Next Generation Sequencing Testing Platform
http://blog.parabasegenomics.com/blog/pressure-biosciences-to-develop-front-end-sample-preparation-for-parabase-genomics’-targeted-next-generation-sequencing-testing-platform
Pressure BioSciences to Develop Front-end Sample Preparation for Parabase Genomics’ Targeted Next Generation Sequencing Testing Platform. Jul 22, 2014 12:58:00 PM. Initial Target of the Parabase Sequencing Service are the Neonatal Intensive Care Units of. US Hospitals with a Goal of Improving the Early Diagnosis of Genetic Diseases. South Easton, MA, July 22, 2014 Pressure BioSciences, Inc. (OTCQB: PBIO) ( PBI or the Company ) and Parabase Genomics. Unfortunately, it is difficult to diagnose genetic dise...
blog.parabasegenomics.com
Limitations of Hearing Loss Testing in Newborns
http://blog.parabasegenomics.com/blog/misconceptions-about-hearing-loss-testing-in-newborns
Limitations of Hearing Loss Testing in Newborns. Mar 7, 2014 12:33:30 AM. Newborn hearing screening has positively affected childhood developmental outcomes. However, limitations remain, including;. High false positive and negative rates of detection for progressive and late onset deafness. Multi-tiered testing is routinely required as symptoms develop. There is no focus on differentiating non-genetic causes, genetic predisposition to ototoxic drugs, and genetic causes of hearing loss. The costs associat...
blog.parabasegenomics.com
Matching Newborns to Rare Therapeutics
http://blog.parabasegenomics.com/blog/matching-newborns-to-rare-therapeutics
Matching Newborns to Rare Therapeutics. Jan 14, 2015 4:02:31 PM. While many people have heard about Newborn Screening I imagine few have heard about neonatal diagnostics. That's because most are waiting for the costs of next gen sequencing to come down before population wide "screening" could begin at an affordable rate since screening is paid for from public funds. Here is a video that shows you how we could do this now and not get stuck focused on the costs;. Why are NICUs not using such a test? We are...
undiagnosed-usa.org
Exome Sequencing
http://www.undiagnosed-usa.org/globalgenes.htm
Exome Sequencing Give Away. Global Genes has partnered with SWAN USA to provide Undiagnosed Rare Disease Patients an opportunity for Free Whole Exome Sequencing. Global Genes Undiagnosed Patient Program started from their first fundraising appeal at their Second Annual Tribute to Champions of Hope on September 21, 2013. Soon after they put together an advisory board to help move this program forward. SWAN USA's founder and president, Amy Clugston is part of the advisory board. PR Newswire . Go to.
geneticobesity.com
Find a Diagnostic Testing Lab - The Genetic Obesity ProjectThe Genetic Obesity Project
http://geneticobesity.com/resources/diagnostic-testing-pomc-lepr-deficiency
About the Genetic Obesity Project. About Rare Genetic Disorders of Obesity. About the MC4 Pathway. Find a Treatment Referral Center. Find a Diagnostic Testing Lab. Patients & Healthcare Professionals:. Join the effort to identify people. I am a Healthcare Professional. I am a Patient or Caregiver. Find a Diagnostic Testing Lab. Find a Treatment Referral Center. Find a Diagnostic Testing Lab. Find a Diagnostic Testing Lab. Baylor Miraca Genetics Laboratories. POMC, PCSK1, LEPR. Test codes: 6860, 6861).
sxeventures.com
Portfolio — SXE VENTURES
http://www.sxeventures.com/portfolio
SOCIAL ENGAGEMENT